BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34913830)

  • 1. Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27.
    Coulonval K; Vercruysse V; Paternot S; Pita JM; Corman R; Raspé E; Roger PP
    Cell Cycle; 2022 Jan; 21(1):12-32. PubMed ID: 34913830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.
    Paternot S; Colleoni B; Bisteau X; Roger PP
    Cell Cycle; 2014; 13(18):2879-88. PubMed ID: 25486476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21.
    Colleoni B; Paternot S; Pita JM; Bisteau X; Coulonval K; Davis RJ; Raspé E; Roger PP
    Oncogene; 2017 Jul; 36(30):4349-4361. PubMed ID: 28368408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point.
    Bisteau X; Paternot S; Colleoni B; Ecker K; Coulonval K; De Groote P; Declercq W; Hengst L; Roger PP
    PLoS Genet; 2013 May; 9(5):e1003546. PubMed ID: 23737759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase.
    Paternot S; Bockstaele L; Bisteau X; Kooken H; Coulonval K; Roger PP
    Cell Cycle; 2010 Feb; 9(4):689-99. PubMed ID: 20107323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes.
    Ray A; James MK; Larochelle S; Fisher RP; Blain SW
    Mol Cell Biol; 2009 Feb; 29(4):986-99. PubMed ID: 19075005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.
    Bockstaele L; Bisteau X; Paternot S; Roger PP
    Mol Cell Biol; 2009 Aug; 29(15):4188-200. PubMed ID: 19487459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors".
    Bockstaele L; Kooken H; Libert F; Paternot S; Dumont JE; de Launoit Y; Roger PP; Coulonval K
    Mol Cell Biol; 2006 Jul; 26(13):5070-85. PubMed ID: 16782892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis.
    Coulonval K; Bockstaele L; Paternot S; Dumont JE; Roger PP
    Exp Cell Res; 2003 Nov; 291(1):135-49. PubMed ID: 14597415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.
    Paternot S; Coulonval K; Dumont JE; Roger PP
    J Biol Chem; 2003 Jul; 278(29):26533-40. PubMed ID: 12730225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
    Pita JM; Raspé E; Coulonval K; Decaussin-Petrucci M; Tarabichi M; Dom G; Libert F; Craciun L; Andry G; Wicquart L; Leteurtre E; Trésallet C; Marlow LA; Copland JA; Durante C; Maenhaut C; Cavaco BM; Dumont JE; Costante G; Roger PP
    Front Endocrinol (Lausanne); 2023; 14():1247542. PubMed ID: 37964967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition.
    Guiley KZ; Stevenson JW; Lou K; Barkovich KJ; Kumarasamy V; Wijeratne TU; Bunch KL; Tripathi S; Knudsen ES; Witkiewicz AK; Shokat KM; Rubin SM
    Science; 2019 Dec; 366(6471):. PubMed ID: 31831640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
    Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
    Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3: differential involvement in the distinct mitogenic modes of thyroid epithelial cells.
    Paternot S; Arsenijevic T; Coulonval K; Bockstaele L; Dumont JE; Roger PP
    Cell Cycle; 2006 Jan; 5(1):61-70. PubMed ID: 16294008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activity of TGF-beta2 on the expression of p27Kip1 and Cdk4 in actively cycling and contact inhibited rabbit corneal endothelial cells.
    Kim TY; Kim WI; Smith RE; Kay EP
    Mol Vis; 2001 Nov; 7():261-70. PubMed ID: 11723444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylations of cyclin-dependent kinase 2 revisited using two-dimensional gel electrophoresis.
    Coulonval K; Bockstaele L; Paternot S; Roger PP
    J Biol Chem; 2003 Dec; 278(52):52052-60. PubMed ID: 14551212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of CDK4/cyclin D3 has implications for models of CDK activation.
    Takaki T; Echalier A; Brown NR; Hunt T; Endicott JA; Noble ME
    Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4171-6. PubMed ID: 19237555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.